Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard T Silver

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Hematology/Oncology Clinics of North America|October 17, 2003
Chronic myeloid leukemiaRichard T Silver
Current Hematology Reports|May 4, 2005
Treatment of polycythemia vera with recombinant interferon alpha (rIFNalpha) or imatinib mesylateRichard T Silver
Cancer|June 29, 2006
Long-term effects of the treatment of polycythemia vera with recombinant interferon-alphaRichard T Silver
The Oncologist|April 1, 2011
Predictive value of in vitro mutation data to guide second-generation tyrosine kinase inhibitor selection: ready for prime time?Richard T Silver
Best Practice & Research. Clinical Haematology|December 5, 2009
The blast phase of chronic myeloid leukaemiaRichard T Silver
Seminars in Thrombosis and Hemostasis|July 1, 2006
Treatment of polycythemia veraRichard T Silver
Current Hematologic Malignancy Reports|April 29, 2010
Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylateRichard T Silver
Blood|October 18, 2014
Life, genes, and death in Ph- MPNsRichard T Silver
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Uncommon or delayed adverse events associated with imatinib treatment for chronic myeloid leukemiaRishard Salie, Richard T Silver
Annals of Hematology|March 28, 2015
Management of chronic myeloid leukemia in blast crisisS Saußele, Richard T Silver
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Hematology/Oncology Clinics of North America|October 17, 2003
Chronic myeloid leukemiaRichard T Silver
Current Hematology Reports|May 4, 2005
Treatment of polycythemia vera with recombinant interferon alpha (rIFNalpha) or imatinib mesylateRichard T Silver
Cancer|June 29, 2006
Long-term effects of the treatment of polycythemia vera with recombinant interferon-alphaRichard T Silver
The Oncologist|April 1, 2011
Predictive value of in vitro mutation data to guide second-generation tyrosine kinase inhibitor selection: ready for prime time?Richard T Silver
Best Practice & Research. Clinical Haematology|December 5, 2009
The blast phase of chronic myeloid leukaemiaRichard T Silver
Seminars in Thrombosis and Hemostasis|July 1, 2006
Treatment of polycythemia veraRichard T Silver
Current Hematologic Malignancy Reports|April 29, 2010
Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylateRichard T Silver
Blood|October 18, 2014
Life, genes, and death in Ph- MPNsRichard T Silver
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Uncommon or delayed adverse events associated with imatinib treatment for chronic myeloid leukemiaRishard Salie, Richard T Silver
Annals of Hematology|March 28, 2015
Management of chronic myeloid leukemia in blast crisisS Saußele, Richard T Silver
Pageof 9